QGEN - Qiagen NV - Stock Price & Dividends

Exchange: USA Stocks • Country: Netherlands • Currency: USD • Type: Common Stock • ISIN: NL0015001WM6

Nucleic Acid, Purification, Instruments, Assays, PCR, Consumables

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a collaboration with the U.S. FBI. The company was founded in 1984 and is headquartered in Venlo, the Netherlands. Web URL: https://www.qiagen.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for QGEN - Qiagen NV  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for QGEN - Qiagen NV  - Stock Price & Dividends

QGEN Stock Overview

Market Cap in USD 10,201m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 1996-06-28

QGEN Stock Ratings

Growth 5y 19.1
Fundamental 55.2
Dividend 37.8
Rel. Performance vs Sector -0.36
Analysts 4.00/5
Fair Price Momentum 44.24 USD
Fair Price DCF 45.49 USD

QGEN Dividends

Dividend Yield 12m 2.85%
Yield on Cost 5y 3.88%
Dividends CAGR 5y 0.00%
Payout Consistency 100.0%

QGEN Growth Ratios

Growth 12m 12.76%
Growth Correlation 12m 59%
Growth Correlation 3m 78%
CAGR 5y 6.36%
CAGR/Mean DD 5y 0.44
Sharpe Ratio 12m 0.35
Alpha vs SP500 12m -2.06
Beta vs SP500 5y weekly 0.43
ValueRay RSI 72.23
Volatility GJR Garch 1y 21.64%
Price / SMA 50 4.51%
Price / SMA 200 6.84%
Current Volume 947k
Average Volume 20d 1445.9k

External Links for QGEN Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of QGEN stocks?
As of September 14, 2024, the stock is trading at USD 46.36 with a total of 946,981 shares traded.
Over the past week, the price has changed by +2.45%, over one month by +0.71%, over three months by +3.03% and over the past year by +10.84%.
What are the forecast for QGEN stock price target?
According to ValueRays Forecast Model, QGEN Qiagen NV will be worth about 48 in September 2025. The stock is currently trading at 46.36. This means that the stock has a potential upside of +3.62%.
Issuer Forecast Upside
Wallstreet Target Price 50.6 9.17
Analysts Target Price 50.2 8.28
ValueRay Target Price 48 3.62